Protocol for stage I of the GaP study (Genetic testing acceptability for Paget's disease of bone): an interview study about genetic testing and preventive treatment: would relatives of people with Paget's disease want testing and treatment if they were available?

被引:10
作者
Langston, Anne L.
Johnston, Marie
Robertson, Clare
Campbell, Marion K.
Entwistle, Vikki A.
Marteau, Theresa M.
McCallum, Marilyn
Ralston, Stuart H.
机构
[1] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen AB25 2ZD, Scotland
[2] Univ Aberdeen, Dept Hlth Psychol, Aberdeen AB25 2ZD, Scotland
[3] Univ Dundee, Social Dimens Hlth Inst, Dundee DD1 4HJ, Scotland
[4] United Med & Dent Sch Guys & St Thomas Hosp, Psychol & Genet Res Grp, Dept Psychol, Hlth Psychol Sect, London SE1 9RT, England
[5] Natl Assoc Relief Pagets Dis, Manchester M28 3HH, Lancs, England
[6] Univ Edinburgh, Western Gen Hosp, Mol Med Ctr, Edinburgh EH4 2XU, Midlothian, Scotland
基金
英国医学研究理事会;
关键词
D O I
10.1186/1472-6963-6-71
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Paget's disease of bone (PDB) is characterised by focal increases in bone turnover, affecting one or more bones throughout the skeleton. This disrupts normal bone architecture and causes pain, deformity, deafness, osteoarthritis, and fractures. Genetic factors are recognised to play a role in PDB and it is now possible to carry out genetic tests for research. In view of this, it is timely to investigate the clinical potential for a programme of genetic testing and preventative treatment for people who have a family history of PDB, to prevent or delay the development of PDB. Evidence from non-genetic conditions, that have effective treatments, demonstrates that patients' beliefs may affect the acceptability and uptake of treatment. Two groups of beliefs ( illness and treatment representations) are likely to be influential. Illness representations describe how people see their illness, as outlined in Leventhal's Self-Regulation Model. Treatment representations describe how people perceive potential treatment for their disease. People offered a programme of genetic testing and treatment will develop their own treatment representations based on what is offered, but the beliefs rather than the objective programme of treatment are likely to determine their willingness to participate. The Theory of Planned Behaviour is a theoretical model that predicts behaviours from people's beliefs about the consequences, social pressures and perceived control over the behaviour, including uptake of treatment. Methods/design: This study aims to examine the acceptability of genetic testing, followed by preventative treatment, to relatives of people with PDB. We aim to interview people with Paget's disease, and their families, from the UK. Our research questions are: 1. What do individuals with Paget's disease think would influence the involvement of their relatives in a programme of genetic testing and preventative treatment? 2. What do relatives of Paget's disease sufferers think would influence them in accepting an offer of a programme of genetic testing and preventative treatment? Discussion: Our research will be informed by relevant psychological theory: primarily the Self-Regulation Model and the Theory of Planned Behaviour. The results of these interviews will inform the development of a separate questionnaire-based study to explore these research questions in greater detail.
引用
收藏
页数:9
相关论文
共 29 条
[1]  
[Anonymous], 1999, ETHICS MED RES HDB G
[2]   Single infusion of zoledronate in Paget's disease of bone: A placebo-controlled, dose-ranging study [J].
Buckler, H ;
Fraser, W ;
Hosking, D ;
Ryan, W ;
Maricic, MJ ;
Singer, F ;
Davie, M ;
Fogelman, I ;
Birbara, CA ;
Moses, AM ;
Lyles, K ;
Selby, P ;
Richardson, P ;
Seaman, J ;
Zelenakas, K ;
Siris, E .
BONE, 1999, 24 (05) :81S-85S
[3]   Two novel mutations at exon 8 of the sequestosome 1 (SQSTM1) gene in an Italian series of patients affected by Paget's disease of bone (PDB) [J].
Falchetti, A ;
Di Stefano, M ;
Marini, F ;
Del Monte, F ;
Mavilia, C ;
Strigoli, D ;
De Feo, ML ;
Isaia, G ;
Masi, L ;
Amedei, A ;
Cioppi, F ;
Ghinoi, V ;
Bongi, SM ;
Di Fede, G ;
Sferrazza, C ;
Rini, GB ;
Melchiorre, D ;
Matucci-Cerinic, M ;
Brandi, ML .
JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (06) :1013-1017
[4]  
Francis J. J., 2004, CONSTRUCTING QUESTIO
[5]   A causal modelling approach to the development of theory-based behaviour change programmes for trial evaluation [J].
Hardeman, W ;
Sutton, S ;
Griffin, S ;
Johnston, M ;
White, A ;
Wareham, NJ ;
Kinmonth, AL .
HEALTH EDUCATION RESEARCH, 2005, 20 (06) :676-687
[6]   PAGETS-DISEASE OF BONE - EARLY AND LATE RESPONSES TO 3 DIFFERENT MODES OF TREATMENT WITH AMINOHYDROXYPROPYLIDENE BISPHOSPHONATE (APD) [J].
HARINCK, HIJ ;
PAPAPOULOS, SE ;
BLANKSMA, HJ ;
MOOLENAAR, AJ ;
VERMEIJ, P ;
BIJVOET, OLM .
BRITISH MEDICAL JOURNAL, 1987, 295 (6609) :1301-1305
[7]   Paget's disease of bone: Evidence for a susceptibility locus on chromosome 18q and for genetic heterogeneity [J].
Haslam, SI ;
Van Hul, W ;
Morales-Piga, A ;
Balemans, W ;
San-Millan, JL ;
Nakatsuka, K ;
Willems, P ;
Haites, NE ;
Ralston, SH .
JOURNAL OF BONE AND MINERAL RESEARCH, 1998, 13 (06) :911-917
[8]   Novel UBA domain mutations of SQSTM1 in Paget's disease of bone:: Genotype phenotype correlation, functional analysis, and structural consequences [J].
Hocking, LJ ;
Lucas, GJA ;
Daroszewska, A ;
Cundy, T ;
Nicholson, GC ;
Donath, J ;
Walsh, JP ;
Finlayson, C ;
Cavey, JR ;
Ciani, B ;
Sheppard, PW ;
Searle, MS ;
Layfield, R ;
Ralston, SH .
JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (07) :1122-1127
[9]   Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget's disease [J].
Hocking, LJ ;
Lucas, GJA ;
Daroszewska, A ;
Mangion, J ;
Olavesen, M ;
Cundy, T ;
Nicholson, GC ;
Ward, L ;
Bennett, ST ;
Wuyts, W ;
Van Hul, W ;
Ralston, SH .
HUMAN MOLECULAR GENETICS, 2002, 11 (22) :2735-2739
[10]  
HORNE R, 1993, J SOC ADMIN PHARM, V10, P150